← 전체 보충제 목록

스트론튬 라넬레이트

Strontium Ranelate

📑 PubMed 21편 🦴 관절·뼈

📚 관련 논문 (21편)

1.
Anti-inflammatory and anti-nociceptive effects of strontium ranelate on the zymosan-induced temporomandibular joint inflammatory hypernociception in rats depend on TNF-α inhibition.
Pharmacological reports : PR 2017 PMID:28587937

1. Pharmacol Rep. 2017 Aug;69(4):764-772. doi: 10.1016/j.pharep.2017.03.007. Epub 2017 Mar 12. Anti-inflammatory and anti-nociceptive effects of strontium ranelate on the zymosan-induced temporomandibular joint inflammatory hypernociception in rats depend on TNF-α inhibition. Alves SM(1), Abreu

2.
Osteoporosis and polypharmacy.
Zeitschrift fur Gerontologie und Geriatrie 2012 PMID:22806642

2. Z Gerontol Geriatr. 2012 Aug;45(6):450-4. doi: 10.1007/s00391-012-0374-7. Osteoporosis and polypharmacy. Gosch M(1), Jeske M, Kammerlander C, Roth T. Author information: (1)Abt. für Innere Medizin und Akutgeriatrie, Landeskrankenhaus Hochzirl, Hochzirl 1, 6170, Zirl, Österreich. markus.gosch@

3.
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
Calcified tissue international 2011 PMID:21637997

3. Calcif Tissue Int. 2011 Aug;89(2):91-104. doi: 10.1007/s00223-011-9499-8. Epub 2011 Jun 3. Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Rizzoli R(1), Reginster JY, Boonen S, Bréart G, Diez-Perez A, Felsenberg D, Kaufman JM, Kanis J

4.
Safety of pharmacotherapy of osteoporosis in cardiology patients.
Cardiology journal 2010 PMID:20690088

4. Cardiol J. 2010;17(4):335-43. Safety of pharmacotherapy of osteoporosis in cardiology patients. Zapolski T(1), Wysokiński A. Author information: (1)Department of Cardiology, Medical University of Lublin, Jaczewskiego 8, Lublin, Poland. zapolia@wp.pl The commonest medical conditions following

5.
Could strontium ranelate have a synergistic role in the treatment of osteoporosis?
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009 PMID:19558313

5. J Bone Miner Res. 2009 Aug;24(8):1354-7. doi: 10.1359/jbmr.090601. Could strontium ranelate have a synergistic role in the treatment of osteoporosis? Blake GM(1), Compston JE, Fogelman I. Author information: (1)King's College London School of Medicine, London, United Kingdom. glen.blake@kcl.

6.
Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
Journal of musculoskeletal & neuronal interactions 2007 PMID:17627088

6. J Musculoskelet Neuronal Interact. 2007 Apr-Jun;7(2):174-84. Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs. Schacht E(1), Dukas L, Richy F. Author information: (1)Zurich Osteoporosis Research Group, Zurich-Munich-Hong Kong, Zurich, Switzerland. During the

7.
[Anabolic treatment for osteoporosis: PTH treatment].
Clinical calcium 2006 PMID:16951472

7. Clin Calcium. 2006 Sep;16(9):1480-85. [Anabolic treatment for osteoporosis: PTH treatment]. [Article in Japanese] Kaji H(1), Sugimoto T. Author information: (1)Kobe University Graduate School of Medicine, Department of Clinical Molecular Medicine, Division of Endocrinology/Metabolism, Neurol

8.
Pharmacokinetics and bioequivalence of two strontium ranelate formulations after single oral administration in healthy Chinese subjects.
Xenobiotica; the fate of foreign compounds in biological systems 2019 PMID:29676197

8. Xenobiotica. 2019 Apr;49(4):457-462. doi: 10.1080/00498254.2018.1465210. Epub 2018 May 8. Pharmacokinetics and bioequivalence of two strontium ranelate formulations after single oral administration in healthy Chinese subjects. Zhang D(1), Du A(1), Wang X(1), Zhang L(1), Yang M(1), Ma J(1), De

9.
Quantification of strontium in human serum by ICP-MS using alternate analyte-free matrix and its application to a pilot bioequivalence study of two strontium ranelate oral formulations in healthy Chinese subjects.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 2015 PMID:25023847

9. J Trace Elem Med Biol. 2015 Jan;29:69-74. doi: 10.1016/j.jtemb.2014.06.008. Epub 2014 Jun 26. Quantification of strontium in human serum by ICP-MS using alternate analyte-free matrix and its application to a pilot bioequivalence study of two strontium ranelate oral formulations in healthy Chi

10.
Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis.
Bone 2009 PMID:19464401

10. Bone. 2009 Sep;45(3):460-5. doi: 10.1016/j.bone.2009.05.014. Epub 2009 May 21. Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis. Liu JM(1), Wai-Chee Kung A, Pheng CS, Zhu HM, Zhang ZL, Wu YY, Xu L, Meng XW, Huang ML, Chung LP, Hussain NH, S

11.
The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
Calcified tissue international 2008 PMID:18843436

11. Calcif Tissue Int. 2008 Nov;83(5):308-14. doi: 10.1007/s00223-008-9180-z. Epub 2008 Oct 9. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis. Hwang JS(1), Chen JF, Yang TS, Wu DJ, Tsai KS, Ho C, Wu CH, Su SL, Wang CJ, Tu ST. Author information: (1)Division o

12.
Impact of anti-fracture medications on bone material and strength properties: a systematic review and meta-analysis.
Frontiers in endocrinology 2024 PMID:39257899

12. Front Endocrinol (Lausanne). 2024 Aug 27;15:1426490. doi: 10.3389/fendo.2024.1426490. eCollection 2024. Impact of anti-fracture medications on bone material and strength properties: a systematic review and meta-analysis. Sharma S(1)(2), Shankar V(1), Rajender S(1)(2), Mithal A(3), Rao SD(4),

13.
Pharmacological agents for bone fracture healing: talking points from recent clinical trials.
Expert opinion on investigational drugs 2023 PMID:37740660

13. Expert Opin Investig Drugs. 2023 Jul-Dec;32(9):855-865. doi: 10.1080/13543784.2023.2263352. Epub 2023 Oct 13. Pharmacological agents for bone fracture healing: talking points from recent clinical trials. Migliorini F(1), Cocconi F(2), Vecchio G(3), Schäefer L(1), Koettnitz J(4), Maffulli N(

14.
Treatment for osteoporosis in people with beta-thalassaemia.
The Cochrane database of systematic reviews 2023 PMID:37159055

14. Cochrane Database Syst Rev. 2023 May 9;5(5):CD010429. doi: 10.1002/14651858.CD010429.pub3. Treatment for osteoporosis in people with beta-thalassaemia. Bhardwaj A(1), Swe KMM(2), Sinha NK(3). Author information: (1)Department of Orthopaedics, Sengkang General Hospital, Singapore, Singapore.

15.
Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2022 PMID:35059777

15. Osteoporos Int. 2022 May;33(5):979-1015. doi: 10.1007/s00198-021-06268-9. Epub 2022 Jan 21. Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review. Wan Y(1), Zeng F(1), Tan H(1), Lu Y(1), Zhang Y(1), Zhao L(2), You R(3). Author information: (1)Department of Pharmacy,

16.
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
The Cochrane database of systematic reviews 2021 PMID:34231877

48. Cochrane Database Syst Rev. 2021 Jul 7;7(7):CD013424. doi: 10.1002/14651858.CD013424.pub2. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D. Hara T(1), Hijikata Y(1), Matsubara Y(2), Watanabe N(3). Au

17.
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis.
PharmacoEconomics 2021 PMID:33026634

17. Pharmacoeconomics. 2021 Feb;39(2):181-209. doi: 10.1007/s40273-020-00965-9. Epub 2020 Oct 7. An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis. Li N(1), Cornelissen D(2), Silverman S(3), Pinto D(4), Si L(5)(6), Kremer I(2), Bours S(7), de Bot R(2)(8), Boo

18.
Clinical Application of Teriparatide in Fracture Prevention: A Systematic Review.
JBJS reviews 2019 PMID:30694878

48. JBJS Rev. 2019 Jan;7(1):e10. doi: 10.2106/JBJS.RVW.18.00052. Clinical Application of Teriparatide in Fracture Prevention: A Systematic Review. Chen Y(1)(2), Liu R(1), Hettinghouse A(1), Wang S(1), Liu G(2), Liu CJ(1)(3). Author information: (1)Department of Orthopaedic Surgery, New York Univ

19.
Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
JAMA 2018 PMID:30575881

18. JAMA. 2018 Dec 25;320(24):2564-2579. doi: 10.1001/jama.2018.19319. Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis. Gregori D(1), Giacovelli G(2), Minto C(1), Barbetta B(2), Gualtieri F(3), Azzo

20.
A systematic review of factors affecting medication adherence among patients with osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2018 PMID:30417253

41. Osteoporos Int. 2018 Dec;29(12):2623-2637. doi: 10.1007/s00198-018-4759-3. Epub 2018 Nov 12. A systematic review of factors affecting medication adherence among patients with osteoporosis. Yeam CT(1), Chia S(1), Tan HCC(1), Kwan YH(1)(2), Fong W(1)(3)(4), Seng JJB(5). Author information: (1

21.
Effects of systemic medication on root resorption associated with orthodontic tooth movement: a systematic review of animal studies.
European journal of orthodontics 2019 PMID:29992228

21. Eur J Orthod. 2019 Aug 8;41(4):346-359. doi: 10.1093/ejo/cjy048. Effects of systemic medication on root resorption associated with orthodontic tooth movement: a systematic review of animal studies. Makrygiannakis MA(1), Kaklamanos EG(1), Athanasiou AE(1). Author information: (1)Hamdan Bin Mo

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.